Literature DB >> 25120687

Dermatofibrosarcoma protuberans of the breast: A case report.

Jin-Qun Jiang1, Zhan Huang2, Lin-Hui Wang3, San-DI Shen2, Hai Lu2.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, metastasizing tumor of the deep dermis and subcutaneous tissue. While it frequently occurs in the trunk and extremities, breast involvement has rarely been reported. In the present case, imaging and pathological technologies were used to detect DFSP of the breast. Surgical excision with wide margins (>3 cm) and pathology revealed spindle cells arranged in storiform patterns and short fascicles which were crucially CD34-positive, enabling a definitive diagnosis prior to surgery.

Entities:  

Keywords:  breast; dermatofibrosarcoma protuberans

Year:  2014        PMID: 25120687      PMCID: PMC4114647          DOI: 10.3892/ol.2014.2291

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


Introduction

Dermatofibrosarcoma protuberans (DFSP) is an uncommon, slow-growing, low-grade sarcoma of putative dermal fibroblastic origin, all recurrence is in situ and rarely metastasizes. The incidence rate is reported to be ~5 per 1 million persons annually (1). Typically, DFSP starts as a red or blue-red coloured nodules. Nodules may gradually develop to become irregularly shaped swellings (2). The five-year survival rate can reach 88.9%. DFSP is relatively resistant to chemotherapy and radiotherapy, thus surgery is the primary treatment for DFSP (3). DFSP frequently involves the trunk. While the head, neck and extremities are commonly involved in DFSP, breast involvement is rare (4). Therefore, DFSP is often misdiagnosed as a benign breast tumor, delaying treatment.

Case report

Patient presentation

A 26-year old woman underwent ablation of a left breast lump, which was diagnosed as DFSP one year previously at YueBei People’s Hospital, Shaoguan, China). Six months after surgery, the patient noticed a lump gradually growing underneath the scarred area of the surgical site of the left breast. Physical examination revealed a brown-red, firm, fixed breast mass with an ill-defined border and smooth margins. The patient had no history of systemic disease or malignancy and the laboratory data were normal.

Ultrasound imaging

Targeted ultrasound of the left breast revealed a 32×9-mm hypoechoic mass lesion with an irregular border at the five o’clock position, 2 mm deep in the skin and ~40 mm from the nipple. No peripheral or internal blood flow was observed. Local invasion of subcutaneous fat and skin was also detected. The mass was classified as a Breast Imaging-Reporting and Data System-ultrasonography 4 lesion (Fig. 1).
Figure 1

Breast ultrasonography revealing the subdermal location of the tumor, its adherence to the skin and its invasion of the subcutaneous tissue layer. No significant blood flow was observed around or within the tumor.

Surgery and follow-up

The mass was excised with 3-cm margins. The patient underwent excisional breast biopsy following surgery. Pathological analysis revealed that the mass consisted of spindle cells arranged in storiform patterns and short fascicles (Fig. 2) that were cluster of differentiation (CD) 34-positive (Fig. 3). The patient was followed-up for ~12 months and did not exhibit any signs of recurrence.
Figure 2

Dermatofibrosarcoma protuberans is composed of single spindle cells and forms a typical mat-like pattern.

Figure 3

Immunohistochemistry shows that dermatofibrosarcoma protuberans is CD34-positive and invades the subcutaneous connective and adipose tissue. (A) Tumor invasion of the adipose tissue. (B) Tumor invasion of the connective tissue. (C) CD34-positive staining. CD34, cluster of differentiation 34.

Discussion

DFSP is a rare cutaneous malignancy that arises from the dermis. The reported incidence of DFSP is approximately five cases per one million individuals per year (5). DFSP was first described by Darier and Ferrand (6) in 1924, and was termed DFSP by Hoffmann (7) in 1925. While DFSP is a low-grade sarcoma, it is capable of infiltration and local recurrence following inadequate excision. DFSP usually involves the trunk. DFSP is also often reported in the limbs, head and neck; however, involvement of the breast is rare, as described previously (8). Typically, DFSP develops as a deep-red or blue-red plaque and grows slowly, usually reaching a size of ≥3 cm (2). DFSP is a relatively rare cancer of the breast and is difficult to diagnose. DFSP may be difficult to distinguish from mammary fibroadenomas due to the lack of peripheral or internal blood flow and the oval or spherical lump observed using B-mode ultrasound. However, the high rate of local spreading and the involved area of the dermis differentiate DFSP from other mammary fibroadenomas (1,9). Surgery is the preferred treatment option for DFSP. Due to the high recurrence rate associated with DFSP, treatment consists of radical excision, which involves either complete surgical excision with wide margins (>3 cm) performed during conventional surgery or Mohs micrographic surgery. Selective or superselective lymphadenectomy is not important. As in the present case, pathological analysis reveals spindle cells arranged in storiform patterns and short fascicles (2,10) that are CD34-positive (3,10,11). Postoperative recurrence has been associated with the index of cell division, cell structure, and incisal margin (12). In the present case, the patient was advised to undergo a physical examination and breast B-mode ultrasound examination twice a year in the first year, followed by annual physical and B-mode ultrasound examinations. Due to the rare involvement of the breast in cases of DFSP, the present study reports this unique case with the clinical features and B-mode ultrasound imaging findings. Diagnostic imaging examinations are useful tools for pre-surgical examination of breast DFSP, as well as for detecting its post-surgical recurrence.
  10 in total

Review 1.  Superficial soft-tissue masses: analysis, diagnosis, and differential considerations.

Authors:  Francesca D Beaman; Mark J Kransdorf; Tricia R Andrews; Mark D Murphey; Lynn K Arcara; James H Keeling
Journal:  Radiographics       Date:  2007 Mar-Apr       Impact factor: 5.333

2.  Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population.

Authors:  T Y Chuang; W P Su; S A Muller
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

3.  Recurrent dermatofibrosarcoma protuberans: A continuing problem.

Authors:  Manisha Makkar; Dayal Pratap Singh; Akshay Rana; Mayank Madan
Journal:  Indian Dermatol Online J       Date:  2013-01

4.  Imaging of dermatofibrosarcoma protuberans of breast.

Authors:  Shi-Zuo Liu; Tzu-Lung Ho; Soa-Min Hsu; Hui-Lun Zhan; Chen-Pin Chou
Journal:  Breast J       Date:  2010-07-06       Impact factor: 2.431

5.  Dermatofibrosarcoma protuberans of the breast.

Authors:  Levent Yeniay; Omer Unalp; Murat Sezak; Rasih Yilmaz
Journal:  Breast J       Date:  2012-08-10       Impact factor: 2.431

6.  Dermatofibrosarcoma protuberans: Our experience of 59 cases.

Authors:  Alessio Stivala; Giuseppe A G Lombardo; Gianluca Pompili; Maria Stella Tarico; Filippo Fraggetta; Rosario Emanuele Perrotta
Journal:  Oncol Lett       Date:  2012-08-30       Impact factor: 2.967

7.  Dermatofibrosarcoma protuberans of the breast: a case report.

Authors:  Francesca Nga-yee Sin; Kwok-wai Wong
Journal:  Clin Imaging       Date:  2011 Sep-Oct       Impact factor: 1.605

Review 8.  Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.

Authors:  Beatriz Llombart; Carlos Serra-Guillén; Carlos Monteagudo; José Antonio López Guerrero; Onofre Sanmartín
Journal:  Semin Diagn Pathol       Date:  2013-02       Impact factor: 3.464

Review 9.  Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review.

Authors:  Majid Foroozan; Jean-François Sei; Mona Amini; Alain Beauchet; Philippe Saiag
Journal:  Arch Dermatol       Date:  2012-09

10.  Dermatofibrosarcoma protuberans of the breast.

Authors:  Jong-Yueh Lin; Shyr-Ming Sheen-Chen; Wayne Hsu; Chao-Cheng Huang; Sheung-Fat Ko; Hock-Liew Eng
Journal:  Tumori       Date:  2008 Nov-Dec
  10 in total
  9 in total

1.  A Rare Breast Tumor: Dermatofibrosarcoma Protuberans.

Authors:  Tevhide Bilgen Özcan; Ezgi Hacıhasanoğlu; Mehmet Ali Nazlı; Şefika Aksoy; Cem Leblebici; Canan Kelten Talu
Journal:  J Breast Health       Date:  2016-01-01

2.  Dermatofibrosarcoma Protruberans of the Breast Skin Simulating Mammary Carcinoma.

Authors:  Prakriti Shukla; Hanni Vasudev Gulwani
Journal:  Indian J Surg Oncol       Date:  2016-11-22

3.  Dermatofibrosarcoma of The Breast - Case Report and Review of Literature.

Authors:  Amr Muhammed; Esraa Elnakib; Mahmoud Nady
Journal:  Eur J Breast Health       Date:  2018-10-01

4.  Operative management of dermatofibrosarcoma protuberans of the breast.

Authors:  Melissa H Kinney; Sally M Knox
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-07

5.  Atrophic dermatofibrosarcoma protuberans with the fusion gene COL1A1-PDGFB detected by RT-PCR using only a single primer pair.

Authors:  Wen-Jun Xu; Ju-Sheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT.

Authors:  Suk Hyun Bae; Ji Young Lee
Journal:  Iran J Radiol       Date:  2016-02-23       Impact factor: 0.212

7.  Dermatofibrosarcoma protuberans of the breast: A case report.

Authors:  Kamil Pohlodek; Iveta Mečiarová; Petr Grossmann; Zdeněk Kinkor
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

Review 8.  Dermatofibrosarcoma Protuberans: Insights into a Rare Soft Tissue Tumor.

Authors:  Aliya Sarhan Al Barwani; Sawsan Taif; Reem Ahmed Al Mazrouai; Khamis Salim Al Muzahmi; Asif Alrawi
Journal:  J Clin Imaging Sci       Date:  2016-04-29

9.  Diagnostic Challenges of Dermatofibrosarcoma Protuberans (DFSP), a Rare Spindle Cell Tumor of Breast.

Authors:  Sanobar Yasmeen Mohammed; Qandeel Sadiq; David Mcgregor; Farhan Khan
Journal:  Cureus       Date:  2021-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.